» Articles » PMID: 20564241

Sclerostin: a Gem from the Genome Leads to Bone-building Antibodies

Overview
Date 2010 Jun 22
PMID 20564241
Citations 51
Authors
Affiliations
Soon will be listed here.
Citing Articles

The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities.

Yu M, Qin K, Fan J, Zhao G, Zhao P, Zeng W Genes Dis. 2024; 11(3):101026.

PMID: 38292186 PMC: 10825312. DOI: 10.1016/j.gendis.2023.04.042.


Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk.

Qin K, Yu M, Fan J, Wang H, Zhao P, Zhao G Genes Dis. 2023; 11(1):103-134.

PMID: 37588235 PMC: 10425814. DOI: 10.1016/j.gendis.2023.01.030.


Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial.

Dai Z, Zhu R, Sheng Z, Qin G, Luo X, Qin Q Front Endocrinol (Lausanne). 2023; 14:1168757.

PMID: 37091850 PMC: 10116854. DOI: 10.3389/fendo.2023.1168757.


Importance of Sclerostin as Bone-Muscle Mediator Crosstalk.

Aryana I, Rini S, Soejono C Ann Geriatr Med Res. 2022; 26(2):72-82.

PMID: 35599457 PMC: 9271392. DOI: 10.4235/agmr.22.0036.


Single Dose of SHR-1222, a Sclerostin Monoclonal Antibody, in Healthy Men and Postmenopausal Women With Low Bone Mass: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Phase I Study.

Dai Z, Fang P, Yan X, Zhu R, Feng Q, Yan Q Front Pharmacol. 2021; 12:770073.

PMID: 34744750 PMC: 8564351. DOI: 10.3389/fphar.2021.770073.